However, when compared with matched-II controls, the differences in these complication rates did not reach statistical significance (all p > 0.05).
← all excerpts
Severe COVID-19 in Patients with Immune-Mediated Rheumatic Disorders: A Case-Control Study.
1
0.0500
0.0500